As of Nov 17
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 58.50, with a high estimate of 60.00 and a low estimate of 57.00. The median estimate represents a +9.57% increase from the last price of 53.39.
The current consensus among 2 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.